Cargando…
Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
OBJECTIVE: To examine the prospective association between blood biomarkers of immune functioning (i.e., innate immune activation, adaptive immunity, and inflammation) and subsequent cognitive decline and clinical progression to mild cognitive impairment (MCI) in cognitively normal individuals. METHO...
Autores principales: | Gross, Alden L., Walker, Keenan A., Moghekar, Abhay R., Pettigrew, Corinne, Soldan, Anja, Albert, Marilyn S., Walston, Jeremy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742958/ https://www.ncbi.nlm.nih.gov/pubmed/31555121 http://dx.doi.org/10.3389/fnagi.2019.00229 |
Ejemplares similares
-
Cortical thickness in relation to clinical symptom onset in preclinical AD
por: Pettigrew, Corinne, et al.
Publicado: (2016) -
Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease
por: Younes, Laurent, et al.
Publicado: (2019) -
Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease
por: Pettigrew, Corinne, et al.
Publicado: (2017) -
Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthood
por: Pettigrew, Corinne, et al.
Publicado: (2022) -
Regional White Matter Hyperintensities and Alzheimer’s Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment
por: Newton, Princess, et al.
Publicado: (2023)